A Guide to Diagnosis and Follow-up of Myelodysplastic Syndrome [Utilization Spotlight]

By Kelley Luedke • March 7, 2016

Share this:

Since 2012, we have been publishing a Utilization Spotlight in every issue of the Communiqué. Each Spotlight offers a quick view of utilization management best practices in action. This Spotlight is from March 2016.

Overview

Myelodysplastic syndromes (MDS) are malignant hematopoietic stem cell disorders that occur primarily in the older adult population and have a yearly incidence of 30 in 100,000 in persons 70 years and older. The eventual clinical outcome for patients with MDS relates to either bone marrow failure or leukemic transformations.

Situation

Myelodysplastic syndromes (MDS) are malignant hematopoietic stem cell disorders that occur primarily in the older adult population and have a yearly incidence of 30 in 100,000 in persons 70 years and older. These disorders are typically associated with a hypercellular bone marrow and low peripheral blood counts, and with significant morbidity and mortality. The eventual clinical outcome for patients with MDS relates to either bone marrow failure or leukemic transformations.

Analysis

Conventional chromosome analysis is the gold standard for identification of the common, recurrent chromosome abnormalities in MDS. Cytogenetic studies can provide confirmatory evidence of clonality in MDS and can be used to provide clinical prognostic or diagnostic information.

Mayo Medical Laboratories Testing

Visit MayoMedicalLaboratories.com to view Mayo Medical Laboratories’ complete MDS test offerings.

• MYEFL / Myelodysplastic Syndrome by Flow Cytometry, Bone Marrow
• CHRBM / Chromosome Analysis, Hematologic Disorders, Bone Marrow
• NGSHM / OncoHeme Next Generation Sequencing (NGS), Hematologic Neoplasms

Additional Resources

• Myelodysplastic Syndrome: Guideline to Diagnosis and Follow-up

Kelley Luedke

Kelley Luedke is a Marketing Channel Manager at Mayo Clinic Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her kitty, and exploring new foods.